XLO Research and Charts

XLO - Xilio Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2026-02-10)

Last 0.54	Change ⇓ -0.01 (0.00%)	Volume 447,788
	Open 0.55	High 0.57	Low 0.52

8EMA (Daily) 0.56	40EMA (Daily) 0.63	50EMA (Daily) 0.64	STO (Daily) 18.791	MACD Hist (Daily) -0.003
8EMA (Weekly) 0.609	40EMA (Weekly) 0.72	50EMA (Weekly) 0.75	STO (Weekly) 9.122	MACD Hist (Weekly) -0.018


Company Profile
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.